id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-D-0367-0008,FDA,FDA-2021-D-0367,Compliance Policy Guide Sec. 540.525 Scombrotoxin (Histamine)-Forming Fish and Fishery Products—Decomposition and Histamine; Reopening of the Comment Period,Notice,Request for Comments,2022-03-15T04:00:00Z,2022,3,2022-03-15T04:00:00Z,2022-04-15T03:59:59Z,2022-04-15T01:00:08Z,2022-05476,0,0,0900006484fc7afb
FDA-2021-D-0367-0006,FDA,FDA-2021-D-0367,Request for Extension from National Fisheries Institute,Other,Request for Extension,2022-02-23T05:00:00Z,2022,2,2022-02-23T05:00:00Z,,2022-02-23T16:34:13Z,,0,0,0900006484f9c2a0